Intervention Review

Oral versus intravenous steroids for treatment of relapses in multiple sclerosis

  1. Jodie M Burton1,*,
  2. Paul W O'Connor2,
  3. Marika Hohol2,
  4. Joseph Beyene3

Editorial Group: Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group

Published Online: 12 DEC 2012

DOI: 10.1002/14651858.CD006921.pub3

How to Cite

Burton JM, O'Connor PW, Hohol M, Beyene J. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD006921. DOI: 10.1002/14651858.CD006921.pub3.

Author Information

  1. 1

    University of Calgary, Department of Clinical Neurosciences, Calgary, Alberta, Canada

  2. 2

    St. Michael's Hospital, Division of Neurology, Toronto, Ontario, Canada

  3. 3

    McMaster University, Clinical Epidemiology and Biostatistics, Hamilton, Ontario, Canada

*Jodie M Burton, Department of Clinical Neurosciences, University of Calgary, 1403 29th St NW, Calgary, Alberta, T2N 2T9, Canada.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 12 DEC 2012


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >